Estrella Immunopharma reported total assets of $1.82M and total liabilities of $9.26M for the quarter ended Jun 2026, down 38.8% year over year. This balance sheet covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.32M | 0.48M | 0.32M | 0.09M | 0.07M | 0.04M | 0.03M | 2.48M | 22.14M | 9.05M | 4.73M | 4.17M | 1.80M | 0.92M | 0.42M | 1.32M | 1.63M | 1.38M | 1.93M | 0.15M | ||
| Cash & Current Investments | 0.32M | 0.48M | 0.32M | 0.09M | 0.07M | 0.04M | 0.03M | 2.48M | 22.14M | 9.05M | 4.73M | 4.17M | 1.80M | 0.92M | 0.42M | 1.32M | 1.63M | 1.38M | 1.93M | 0.15M | ||
| Receivables - NetNet Receivables | 0.27M | 0.27M | ||||||||||||||||||||
| Receivables | 0.27M | 0.27M | ||||||||||||||||||||
| Prepaid Assets | 0.01M | 0.14M | 0.11M | 0.04M | 0.09M | 0.01M | 0.05M | 0.09M | 0.14M | 0.40M | 3.50M | 0.29M | 0.44M | 0.72M | 0.52M | 0.16M | 0.40M | 0.29M | 0.23M | 0.18M | ||
| Current Assets | 0.78M | 0.62M | 0.43M | 0.13M | 0.16M | 0.05M | 0.08M | 2.75M | 9.45M | 8.63M | 4.45M | 2.24M | 1.64M | 0.94M | 1.48M | 2.02M | 1.68M | 2.16M | 1.82M | |||
| Non-Current Assets | ||||||||||||||||||||||
| Long-Term Investments | 45.19M | 45.19M | 45.19M | 45.26M | 45.46M | 9.67M | 9.70M | 9.79M | 5.07M | 0.05M | 0.05M | 0.05M | 0.05M | |||||||||
| Other Non-Current Assets | 0.28M | 27.35M | 1.50M | 1.50M | 1.50M | 1.50M | 1.50M | 1.50M | 1.50M | |||||||||||||
| Non-Current Assets | 45.19M | 45.19M | 45.19M | 45.26M | 45.46M | 9.67M | 9.70M | 0.28M | 1.50M | 1.50M | 1.50M | 1.50M | 1.50M | 1.50M | 1.50M | |||||||
| Assets | 45.97M | 45.80M | 45.62M | 45.38M | 45.62M | 9.72M | 9.78M | 3.03M | 27.35M | 9.45M | 8.63M | 4.45M | 3.74M | 3.14M | 2.44M | 2.98M | 3.52M | 3.18M | 3.66M | 1.82M | ||
| Liabilities | ||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||
| Accounts Payables | 0.00M | 0.00M | 0.01M | 0.11M | 0.21M | 0.33M | 0.38M | 0.40M | 9.34M | 0.27M | 0.09M | 0.13M | 0.19M | 0.20M | 0.12M | 0.11M | 0.08M | 0.24M | 0.18M | 0.26M | ||
| Notes Payables | 0.50M | 0.14M | 0.27M | 0.30M | ||||||||||||||||||
| Payables | 0.00M | 0.00M | 0.01M | 0.11M | 0.71M | 0.33M | 0.51M | 0.67M | 9.64M | 0.27M | 0.09M | 0.13M | 0.19M | 0.20M | 0.12M | 0.11M | 0.08M | 0.24M | 0.18M | 0.26M | ||
| Accumulated Expenses | 0.12M | 0.01M | 0.01M | 0.17M | 0.00M | 2.75M | 2.80M | 8.20M | 8.80M | 12.90M | 12.40M | 16.60M | 16.60M | |||||||||
| Other Accumulated Expenses | 0.40M | 5.07M | 0.00M | 391.00 | 347.00 | 0.00M | 0.01M | 0.00M | 0.02M | 0.00M | 0.00M | |||||||||||
| Current Taxes | 0.05M | 0.09M | 0.00M | 0.00M | 0.04M | 0.04M | 0.04M | 0.04M | 50.00 | 50.00 | ||||||||||||
| Total Current Liabilities | 0.10M | 0.07M | 0.03M | 0.15M | 0.74M | 1.07M | 1.22M | 9.76M | 17.28M | 0.40M | 0.14M | 0.18M | 2.99M | 3.00M | 4.28M | 9.08M | 13.36M | 13.54M | 8.93M | 9.30M | ||
| Non-Current Liabilities | ||||||||||||||||||||||
| Preferred Stock Liabilities | 45.19M | 45.19M | 45.19M | 45.19M | 45.32M | 9.33M | 9.54M | 9.75M | ||||||||||||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 0.03M | 0.01M | 0.01M | |||||||||||||||||||
| Other Non-Current Liabilities | 0.01M | 0.32M | 0.19M | 0.39M | 0.36M | 0.47M | 0.69M | |||||||||||||||
| Total Non-Current Liabilities | 0.01M | 17.28M | 0.40M | 0.14M | 0.18M | 2.99M | 2.68M | 8.89M | 12.97M | 13.19M | 8.46M | 8.57M | ||||||||||
| Total Liabilities | 46.84M | 46.81M | 46.77M | 46.42M | 49.44M | 16.20M | 18.90M | 14.77M | 17.28M | 0.40M | 0.14M | 0.18M | 2.99M | 3.00M | 4.28M | 9.08M | 13.36M | 13.54M | 8.93M | 9.26M | ||
| Shareholder's Equity | ||||||||||||||||||||||
| Total Debt | 0.50M | 0.14M | 0.27M | 0.30M | ||||||||||||||||||
| Common Equity | -0.87M | -1.01M | -1.15M | -1.04M | -3.82M | -6.48M | -9.11M | -11.74M | 10.07M | 9.05M | 8.49M | 4.27M | 0.75M | 0.14M | -1.83M | -6.09M | -9.84M | -10.37M | -5.27M | -7.43M | ||
| Liabilities and Shareholders Equity | 45.97M | 45.80M | 45.62M | 45.38M | 45.62M | 9.72M | 9.78M | 3.03M | 27.35M | 9.45M | 8.63M | 4.45M | 3.74M | 3.14M | 2.44M | 2.98M | 3.52M | 3.18M | 3.66M | 1.82M | ||
| Treasury Shares | 0.07M | 0.32M | 0.43M | 0.49M | 0.52M | 0.52M | 0.52M | 0.52M | 0.52M | 0.52M | ||||||||||||
| Retained Earnings | -0.87M | -1.01M | -1.15M | -1.51M | -1.98M | -2.26M | -2.53M | -12.19M | -14.06M | -15.10M | -15.55M | -19.50M | -22.90M | -23.93M | -26.03M | -31.60M | -36.40M | -36.99M | -39.30M | -41.60M | ||
| Preferred Shares | 5.00M | 0.50M | 0.50M | 0.50M | 0.50M |
Pull Estrella Immunopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ESLA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ESLA", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ESLA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();